A citation-based method for searching scientific literature

Stefania Scarpino, Federica Pulcini, Arianna Di Napoli, Maria Giubettini, Luigi Ruco. Lung Cancer 2015
Times Cited: 12







List of co-cited articles
27 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.
Neal I Lindeman, Philip T Cagle, Mary Beth Beasley, Dhananjay Arun Chitale, Sanja Dacic, Giuseppe Giaccone, Robert Brian Jenkins, David J Kwiatkowski, Juan-Sebastian Saldivar, Jeremy Squire,[...]. J Thorac Oncol 2013
585
33

EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.
Gillian Ellison, Guanshan Zhu, Alexandros Moulis, Simon Dearden, Georgina Speake, Rose McCormack. J Clin Pathol 2013
223
33

Sample features associated with success rates in population-based EGFR mutation testing.
Carolyn J Shiau, Jesse P Babwah, Gilda da Cunha Santos, Jenna R Sykes, Scott L Boerner, William R Geddie, Natasha B Leighl, Cuihong Wei, Suzanne Kamel-Reid, David M Hwang,[...]. J Thorac Oncol 2014
52
25

Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop.
Robert Pirker, Felix J F Herth, Keith M Kerr, Martin Filipits, Miquel Taron, David Gandara, Fred R Hirsch, Dominique Grunenwald, Helmut Popper, Egbert Smit,[...]. J Thorac Oncol 2010
215
25

The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group.
Erik Thunnissen, Keith M Kerr, Felix J F Herth, Sylvie Lantuejoul, Mauro Papotti, Robert C Rintoul, Giulio Rossi, Birgit G Skov, Birgit Weynand, Lukas Bubendorf,[...]. Lung Cancer 2012
156
16

Gefitinib treatment in EGFR mutated caucasian NSCLC: circulating-free tumor DNA as a surrogate for determination of EGFR status.
Jean-Yves Douillard, Gyula Ostoros, Manuel Cobo, Tudor Ciuleanu, Rebecca Cole, Gael McWalter, Jill Walker, Simon Dearden, Alan Webster, Tsveta Milenkova,[...]. J Thorac Oncol 2014
351
16

Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer.
K M Kerr, L Bubendorf, M J Edelman, A Marchetti, T Mok, S Novello, K O'Byrne, R Stahel, S Peters, E Felip. Ann Oncol 2014
182
16

EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment.
Antonio Marchetti, Carla Martella, Lara Felicioni, Fabio Barassi, Simona Salvatore, Antonio Chella, Pier P Camplese, Teodorico Iarussi, Felice Mucilli, Andrea Mezzetti,[...]. J Clin Oncol 2005
665
16

EGFR gene status in cytological samples of nonsmall cell lung carcinoma: controversies and opportunities.
Gilda da Cunha Santos, Mauro Ajaj Saieg, William Geddie, Natasha Leighl. Cancer Cytopathol 2011
87
16

Evaluation of EGFR mutation status in cytology specimens: an institutional experience.
D L Aisner, C Deshpande, Z Baloch, C D Watt, L A Litzky, B Malhotra, A R Sepulveda, C Langer, T Evans, V M Van Deerlin. Diagn Cytopathol 2013
53
16

Molecular pathology of non-small cell lung cancer: a practical guide.
Dara L Aisner, Carrie B Marshall. Am J Clin Pathol 2012
86
16

EGFR mutation detection in NSCLC--assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC.
Roland Penzel, Christine Sers, Yuan Chen, Ulrich Lehmann-Mühlenhoff, Sabine Merkelbach-Bruse, Andreas Jung, Thomas Kirchner, Reinhard Büttner, Hans H Kreipe, Iver Petersen,[...]. Virchows Arch 2011
65
16

Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNA.
Junji Uchida, Kikuya Kato, Yoji Kukita, Toru Kumagai, Kazumi Nishino, Haruko Daga, Izumi Nagatomo, Takako Inoue, Madoka Kimura, Shigeyuki Oba,[...]. Clin Chem 2015
86
16

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.
Tony S Mok, Yi-Long Wu, Sumitra Thongprasert, Chih-Hsin Yang, Da-Tong Chu, Nagahiro Saijo, Patrapim Sunpaweravong, Baohui Han, Benjamin Margono, Yukito Ichinose,[...]. N Engl J Med 2009
16

Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell-Free DNA from Patients with Advanced Non-Small Cell Lung Cancer.
Guanshan Zhu, Xin Ye, Zhengwei Dong, Ya Chao Lu, Yun Sun, Yi Liu, Rose McCormack, Yi Gu, Xiaoqing Liu. J Mol Diagn 2015
161
16

Global cancer statistics, 2012.
Lindsey A Torre, Freddie Bray, Rebecca L Siegel, Jacques Ferlay, Joannie Lortet-Tieulent, Ahmedin Jemal. CA Cancer J Clin 2015
16

Assessment of EGFR and KRAS mutation status from FNAs and core-needle biopsies of non-small cell lung cancer.
Maria D Lozano, Tania Labiano, Jose Echeveste, Alfonso Gurpide, Salvador Martín-Algarra, Guili Zhang, Abha Sharma, John F Palma. Cancer Cytopathol 2015
23
16

Reliability of the peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations integrated into the clinical practice for non-small cell lung cancers.
Tomoaki Tanaka, Yoshiaki Nagai, Hitoshi Miyazawa, Nobuyuki Koyama, Suguru Matsuoka, Akihisa Sutani, Huqun, Kiyoshi Udagawa, Yoshitake Murayama, Makoto Nagata,[...]. Cancer Sci 2007
80
16

Detection of mutations in EGFR in circulating lung-cancer cells.
Shyamala Maheswaran, Lecia V Sequist, Sunitha Nagrath, Lindsey Ulkus, Brian Brannigan, Chey V Collura, Elizabeth Inserra, Sven Diederichs, A John Iafrate, Daphne W Bell,[...]. N Engl J Med 2008
16



A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening.
Pasi A Jänne, Ana M Borras, Yanan Kuang, Andrew M Rogers, Victoria A Joshi, Hema Liyanage, Neal Lindeman, Jeffrey C Lee, Balazs Halmos, Elizabeth A Maher,[...]. Clin Cancer Res 2006
181
16

Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy.
Tony Mok, Yi-Long Wu, Jin Soo Lee, Chong-Jen Yu, Virote Sriuranpong, Jennifer Sandoval-Tan, Guia Ladrera, Sumitra Thongprasert, Vichien Srimuninnimit, Meilin Liao,[...]. Clin Cancer Res 2015
365
16

A proposal for cellularity assessment for EGFR mutational analysis with a correlation with DNA yield and evaluation of the number of sections obtained from cell blocks for immunohistochemistry in non-small cell lung carcinoma.
Gilda da Cunha Santos, Tyler Wyeth, Allie Reid, Mauro Ajaj Saieg, Bethany Pitcher, Melania Pintilie, Suzanne Kamel-Reid, Ming Sound Tsao. J Clin Pathol 2016
13
16

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
16

EGFR, KRAS, BRAF and HER2 testing in metastatic lung adenocarcinoma: Value of testing on samples with poor specimen adequacy and analysis of discrepancies.
Fabien Forest, Marie-Laure Stachowicz, François Casteillo, Georgia Karpathiou, Fabienne Gouzy-Grosjean, Colette Guilaubey, Michèle Cottier, Julie Beal, Alix Clemenson, Michel Péoc'h. Exp Mol Pathol 2017
17
16

Next-generation sequencing of lung cancer EGFR exons 18-21 allows effective molecular diagnosis of small routine samples (cytology and biopsy).
Dario de Biase, Michela Visani, Umberto Malapelle, Francesca Simonato, Valentina Cesari, Claudio Bellevicine, Annalisa Pession, Giancarlo Troncone, Ambrogio Fassina, Giovanni Tallini. PLoS One 2013
66
16

The suitability of small biopsy and cytology specimens for EGFR and other mutation testing in non-small cell lung cancer.
Shu Wang, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina I Selinger, Sandra A O'Toole, Wendy A Cooper. Transl Lung Cancer Res 2015
30
8

Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.
Liza C Villaruz, Mark A Socinski, Shira Abberbock, Lynne D Berry, Bruce E Johnson, David J Kwiatkowski, A John Iafrate, Marileila Varella-Garcia, Wilbur A Franklin, D Ross Camidge,[...]. Cancer 2015
77
8

Factors related to diagnostic yield of transbronchial biopsy using endobronchial ultrasonography with a guide sheath in small peripheral pulmonary lesions.
Noriyuki Yamada, Koichi Yamazaki, Noriaki Kurimoto, Hajime Asahina, Eiki Kikuchi, Naofumi Shinagawa, Satoshi Oizumi, Masaharu Nishimura. Chest 2007
164
8

Preparation of DNA from cytological material: effects of fixation, staining, and mounting medium on DNA yield and quality.
Annika Dejmek, Nooreldin Zendehrokh, Malgorzata Tomaszewska, Anders Edsjö. Cancer Cytopathol 2013
79
8

2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease.
B Besse, A Adjei, P Baas, P Meldgaard, M Nicolson, L Paz-Ares, M Reck, E F Smit, K Syrigos, R Stahel,[...]. Ann Oncol 2014
183
8

Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment.
Antonio Marchetti, Maela Del Grammastro, Lara Felicioni, Sara Malatesta, Giampaolo Filice, Irene Centi, Tommaso De Pas, Armando Santoro, Antonio Chella, Alba Ariela Brandes,[...]. PLoS One 2014
116
8

Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study.
Shirish M Gadgeel, Leena Gandhi, Gregory J Riely, Alberto A Chiappori, Howard L West, Michele C Azada, Peter N Morcos, Ruey-Min Lee, Linta Garcia, Li Yu,[...]. Lancet Oncol 2014
507
8

Endobronchial ultrasonography with guide-sheath for peripheral pulmonary lesions.
E Kikuchi, K Yamazaki, N Sukoh, J Kikuchi, H Asahina, M Imura, Y Onodera, N Kurimoto, I Kinoshita, M Nishimura. Eur Respir J 2004
146
8

Molecular analysis of liquid cytological samples collected by bronchoscopy with radial endobronchial ultrasonography and guide sheath.
Naomi Iwabu, Takehiro Izumo, Yukiko Nakamura, Christine Chavez, Takaaki Tsuchida, Shinji Sasada. Ann Thorac Cardiovasc Surg 2014
4
25

Progression-Free and Overall Survival in ALK-Positive NSCLC Patients Treated with Sequential Crizotinib and Ceritinib.
Justin F Gainor, Daniel S W Tan, Tomasso De Pas, Benjamin J Solomon, Aziah Ahmad, Chiara Lazzari, Filippo de Marinis, Gianluca Spitaleri, Katherine Schultz, Luc Friboulet,[...]. Clin Cancer Res 2015
135
8

Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.
Stephanie Cardarella, Atsuko Ogino, Mizuki Nishino, Mohit Butaney, Jeanne Shen, Christine Lydon, Beow Y Yeap, Lynette M Sholl, Bruce E Johnson, Pasi A Jänne. Clin Cancer Res 2013
241
8

High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer.
E Pailler, N Auger, C R Lindsay, P Vielh, A Islas-Morris-Hernandez, I Borget, M Ngo-Camus, D Planchard, J-C Soria, B Besse,[...]. Ann Oncol 2015
88
8

Adequacy of CT-guided biopsies with histomolecular subtyping of pulmonary adenocarcinomas: influence of ATS/ERS/IASLC guidelines.
Gilbert R Ferretti, Benoit Busser, Florence de Fraipont, Emilie Reymond, Anne McLeer-Florin, Lena Mescam-Mancini, Denis Moro-Sibilot, Elisabeth Brambilla, Sylvie Lantuejoul. Lung Cancer 2013
33
8


Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort.
Julien Mazières, Gérard Zalcman, Lucio Crinò, Pamela Biondani, Fabrice Barlesi, Thomas Filleron, Anne-Marie C Dingemans, Hervé Léna, Isabelle Monnet, Sacha I Rothschild,[...]. J Clin Oncol 2015
249
8

Diagnostic yield and safety of electromagnetic navigation bronchoscopy for lung nodules: a systematic review and meta-analysis.
Gregoire Gex, Jacques A Pralong, Christophe Combescure, Luis Seijo, Thierry Rochat, Paola M Soccal. Respiration 2014
161
8

Suitability of computed tomography-guided biopsy specimens for subtyping and genotyping of non-small-cell lung cancer.
Shih-Hsin Hsiao, Chi-Li Chung, Chi-Ming Lee, Wei-Yu Chen, Yu-Ting Chou, Zhung-Han Wu, Yi-Chie Chen, Sey-En Lin. Clin Lung Cancer 2013
18
8


Feasibility and accuracy of molecular testing in specimens obtained with small biopsy forceps: comparison with the results of surgical specimens.
Masahide Oki, Yasushi Yatabe, Hideo Saka, Chiyoe Kitagawa, Yoshihito Kogure, Shu Ichihara, Suzuko Moritani. Respiration 2015
9
11


Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives.
Julien Mazières, Solange Peters, Benoit Lepage, Alexis B Cortot, Fabrice Barlesi, Michéle Beau-Faller, Benjamin Besse, Hélène Blons, Audrey Mansuet-Lupo, Thierry Urban,[...]. J Clin Oncol 2013
430
8

Virtual Bronchoscopy Using OsiriX.
Atsushi Sano, Takehiro Tsuchiya. J Bronchology Interv Pulmonol 2014
6
16

Multimodality bronchoscopic diagnosis of peripheral lung lesions: a randomized controlled trial.
Ralf Eberhardt, Devanand Anantham, Armin Ernst, David Feller-Kopman, Felix Herth. Am J Respir Crit Care Med 2007
346
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.